We bring you the latest news from the healthcare about the health care in the United Kingdom.

donderdag 25 januari 2018

The Lancet: [Articles] Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study

[Articles] Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study
Pembrolizumab is a promising treatment option in patients with thymic carcinoma. Because severe autoimmune disorders are more frequent in thymic carcinoma than in other tumour types, careful monitoring is essential.
Read more

[News] New cancer blood test developed
An international team of researchers has developed a blood test that can identify the presence of eight different types of cancer.
Read more

[News] HIPEC improves survival in stage III epithelial ovarian cancer
The addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to interval cytoreductive surgery improves outcomes in patients receiving neoadjuvant chemotherapy for stage III epithelial ovarian cancer, according to a recent study.
Read more

[Comment] Immune checkpoint inhibitors: the next step for thymic carcinomas
Thymic carcinoma is a rare cancer with few available treatment options. Over the past few years, chemotherapy for thymic malignancies, comprising thymic carcinomas and thymomas, has achieved minimal success. Therefore, a more promising, targeted approach is required.1
Read more

[News] Nivolumab plus ipilimumab in metastatic colorectal cancer
Patients with DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer might benefit from combined nivolumab and ipilimumab immunotherapy, according to results from a recent study.
Read more